NDC Code(s) : 50228-379-30, 50228-379-90, 50228-379-05, 50228-379-10
Packager : ScieGen Pharmaceuticals Inc
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
EzetimibeEzetimibe TABLET | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
LABELER - ScieGen Pharmaceuticals Inc(079391286) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
ScieGen Pharmaceuticals Inc | 079391286 | analysis(50228-379), manufacture(50228-379) |
PRINCIPAL DISPLAY PANEL
NDC 50228-379-30
Ezetimibe
Tablets, USP
10 mg
30 Tablets Rx Only
ScieGen Pharmaceuticals, Inc.
NDC 50228-379-90
Ezetimibe
Tablets, USP
10 mg
90 Tablets Rx Only
ScieGen Pharmaceuticals, Inc.
NDC 50228-379-05
Ezetimibe
Tablets, USP
10 mg
500 Tablets Rx Only
ScieGen Pharmaceuticals, Inc.
NDC 50228-379-10
Ezetimibe
Tablets, USP
10 mg
1,000 Tablets Rx Only
ScieGen Pharmaceuticals, Inc.